Vanda Pharmaceuticals Inc. (VNDA) › Cash & EquivalentsVanda Pharmaceuticals Inc. (VNDA) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2008-12-31: $39.08M2009-12-31: $205.29M2010-12-31: $42.56M2011-12-31: $87.92M2012-12-31: $88.77M2013-12-31: $64.76M2014-12-31: $60.90M2015-12-31: $50.84M2016-12-31: $40.43M2017-12-31: $33.63M2018-12-31: $61.01M2019-12-31: $45.07M2020-12-31: $61.03M2021-12-31: $52.07M2022-12-31: $135.03M2023-12-31: $135.82M2024-12-31: $102.32M2025-12-31: $84.85M$84.85M2008-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$84.85M-17.1%2026-02-12Balance as of period end2024-12-31$102.32M-24.7%2026-02-12Balance as of period end2023-12-31$135.82M+0.6%2025-02-14Balance as of period end2022-12-31$135.03M+159.3%2024-02-08Balance as of period end2021-12-31$52.07M-14.7%2023-02-09Balance as of period end2020-12-31$61.03M+35.4%2022-02-24Balance as of period end2019-12-31$45.07M-26.1%2021-02-11Balance as of period end2018-12-31$61.01M+81.4%2020-02-26Balance as of period end2017-12-31$33.63M-16.8%2019-02-19Balance as of period end2016-12-31$40.43M-20.5%2018-02-15Balance as of period end2015-12-31$50.84M-16.5%2018-02-15Balance as of period end2014-12-31$60.90M-6.0%2018-02-15Balance as of period end2013-12-31$64.76M-27.0%2017-02-17Balance as of period end2012-12-31$88.77M+1.0%2016-02-12Balance as of period end2011-12-31$87.92M+106.6%2015-03-13Balance as of period end2010-12-31$42.56M-79.3%2014-02-25Balance as of period end2009-12-31$205.29M+425.3%2013-02-26Balance as of period end2008-12-31$39.08M—2012-03-09Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)